Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand

Diabetes Research and Clinical Practice

Volumn 84, Issue 1, 2009, Pages 92-98

  Aekplakorn, Wichai ^a   Srivanichakorn, Supattra ^b   Sangwatanaroj, Somkiat ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Diabetes; Metabolic syndrome; Microalbuminuria; Primary care

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; STATISTICAL MODEL; THAILAND; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 62349128914     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.12.020     Document Type: Article

References (37)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Aekplakorn W., et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 26 (2003) 2758-2763
3. Berrut G., Bouhanick B., Fabbri P., Guilloteau G., Bled F., Le Jeune J.J., et al. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Clin. Nephrol. 48 (1997) 92-97
4. Keane W.F., Brenner B.M., de Zeeuw D., Grunfeld J.P., McGill J., Mitch W.E., et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 63 (2003) 1499-1507
5. American Diabetes Association. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 (2008) S12-S54
6. Wu A.Y., Kong N.C., de Leon F.A., Pan C.Y., Tai T.Y., Yeung V.T., et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the microalbuminuria prevalence (MAP) study. Diabetologia 48 (2005) 17-26
7. Buranakitjaroen P., Deerochanawong C., and Bunnag P. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand. J. Med. Assoc. Thai. 88 (2005) 1624-1629
8. Retnakaran R., et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 55 (2006) 1832-1839
9. Cederholm J., Eliasson B., Nilsson P.M., Weiss L., and Gudbjörnsdottir S. Steering Committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res. Clin. Pract. 67 (2005) 258-266
10. Ravid M., Brosh D., Ravid-Safran D., Levy Z., and Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch. Intern. Med. 158 (1998) 998-1004
11. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med. 140 (2004) 167-174
12. Bianchi C., Penno G., Daniele G., Russo E., Giovannitti M.G., Del Prato S., et al. The metabolic syndrome is related to albuminuria in type 2 diabetes. Diabetes Med. 25 (2008) 1412-1418
13. Tozawa M., Iseki K., Iseki C., Oshiro S., Ikemiya Y., and Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 62 (2002) 1743-1749
14. Muntner P., Coresh J., Smith J.C., Eckfeldt J., and Klag M.J. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 58 (2000) 293-301
15. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
16. Coonrod B.A., Ellis D., Becker D.J., Bunker C.H., Kelsey S.F., Lloyd C.E., et al. Predictors of microalbuminuria in individuals with IDDM Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 16 (1993) 1376-1383
17. Bruno G., Cavallo-Perin P., Bargero G., Borra M., Calvi V., D'Errico N., et al. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 19 (1996) 43-47
18. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
19. Pettitt D.J., Saad M.F., Bennett P.H., Nelson R.G., and Knowler W.C. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33 (1990) 438-443
20. Al-Maskari F., El-Sadig M., and Obineche E. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. BMC Nephrol. 9 (2008) 1
21. Burden A.C., McNally P.G., Feehally J., and Walls J. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabetes Med. 9 (1992) 641-645
22. Kohler K.A., McClellan W.M., Ziemer D.C., Kleinbaum D.G., and Boring J.R. Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes. Am. J. Kidney Dis. 36 (2000) 903-913
23. Tentolouris N., Stylianou A., Lourida E., Perrea D., Kyriaki D., Papavasiliou E.C., et al. High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria. J. Lipid Res. 48 (2007) 218-225
24. Park J.Y., Kim H.K., Chung Y.E., Kim S.W., Hong S.K., and Lee K.U. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 21 (1998) 530-534
25. Ansquer J.C., Foucher C., Rattier S., Taskinen M.R., and Steiner G. DAIS Investigators. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). Am. J. Kidney Dis. 45 (2005) 485-493
26. Savage S., Nagel N.J., Estacio R.O., Lukken N., and Schrier R.W. Clinical factors associated with urinary albumin excretion in type II diabetes. Am. J. Kidney Dis. 25 (1995) 836-844
27. Klausen K.P., Parving H.H., Scharling H., and Jensen J.S. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J. Intern. Med. 262 (2007) 470-478
28. Lu B., Wen J., Song X.Y., et al. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res. Clin. Pract. 75 (2007) 184-192
29. Yip J., Mattock M.B., Morocutti A., Sethi M., Trevisan R., and Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342 (1993) 883-887
30. Tseng C.H. Waist-to-height ratio is independently and better associated with urinary albumin excretion rate than waist circumference or waist-to-hip ratio in chinese adult type 2 diabetic women but not men. Diabetes Care 28 (2005) 2249-2251
31. Iseki K., Tokashiki K., Iseki C., Kohagura K., Kinjo K., and Takishita S. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease. Clin. Exp. Nephrol. 12 (2008) 363-369
32. Krilithichai U., Supaporn T., and Lakyanon S. Thailand registry of renal replacement therapy: a report of 1997-2003. J. Nephrol. Soc. Thai. 9 (2003) 210-225
33. Aekplakorn W., Abbott-Klafter J., Premgamone A., Dhanamun B., Chaikittiporn C., Chongsuvivatwong V., et al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 30 (2007) 2007-2012
34. Gimeno-Orna J.A., Molinero-Herguedas E., Lou-Arnal L.M., Boned-Juliani B., Labrador-Fuster T., and Guiu-Campos M. Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome. Rev. Esp. Cardiol. 60 (2007) 1202-1205
35. Porapakkham Y., Pattaraarchachai J., and Aekplakorn W. Prevalence awareness, treatment and control of hypertension and diabetes mellitus among the elderly: the 2004 National Health Examination Survey III, Thailand. Singapore Med. J. 49 (2008) 868-873
36. Tseng C.H. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int. 68 (2005) 796-801
37. Tseng C.H. Betel nut chewing is independently associated with urinary albumin excretion rate in type 2 diabetic patients. Diabetes Care 29 (2006) 462-463